MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

NATURAL HEALTH TRENDS CORP (NHTC)

NATURAL HEALTH TRENDS CORP (NHTC)

|||

Cash Flow Overview

Change in Cash
$2,408K
Free Cash flow
-$912K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from maturities of mark...
    • Accounts payable
    • Noncash lease expense
    • Others
Negative Cash Flow Breakdown
    • Repurchase of common stock
    • Purchases of marketable securiti...
    • Dividends paid
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net income (loss)
-154 -588 -431 137
Depreciation and amortization
11 22 28 59
Net accretion of marketable securities
-29 -58 -103 -214
Share-based compensation
0 29 35 68
Noncash lease expense
286 288 279 573
Deferred income taxes
0 -37 142 -3
Inventories
-43 -113 -636 -525
Other current assets
57 -542 -280 -402
Income taxes payable
NaN -1 0 -4,901
Other assets
58 39 267 334
Accounts payable
719 -455 49 65
Accrued commissions
-268 203 -120 -194
Other accrued expenses
-263 -51 154 -110
Deferred revenue
-534 -432 -111 -311
Amounts held in ewallets
-80 -138 -137 -170
Operating lease liabilities
-294 -284 -297 -561
Other current liabilities
-119 -73 -24 -182
Net cash provided by (used in) operating activities
-797 -959 113 -5,151
Purchases of property and equipment
115 5 43 20
Purchases of marketable securities
1,097 11,731 11,459 27,552
Proceeds from maturities of marketable securities
11,156 7,339 17,404 34,215
Net cash provided by investing activities
9,944 -4,397 5,902 6,643
Repurchase of common stock
5,870 NaN NaN NaN
Dividends paid
858 2,301 2,303 4,606
Net cash used in financing activities
-6,728 -2,301 -2,303 -4,606
Effect of exchange rates on cash, cash equivalents and restricted cash
-11 106 88 118
Net increase in cash, cash equivalents and restricted cash
2,408 -7,551 3,800 -2,996
Cash, cash equivalents and restricted cash, beginning of period
14,371 NaN 13,567 NaN
Cash, cash equivalents and restricted cash, end of period
9,228 NaN 14,371 NaN
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from maturitiesof marketable...$11,156K Net cash provided byinvesting activities$9,944K Canceled cashflow$1,212K Net increase incash, cash...$2,408K Canceled cashflow$7,536K Purchases of marketablesecurities$1,097K Purchases of property andequipment$115K Accounts payable$719K Noncash lease expense$286K Inventories-$43K Depreciation andamortization$11K Net cash used infinancing activities-$6,728K Net cash provided by(used in) operating...-$797K Effect of exchangerates on cash, cash...-$11K Canceled cashflow$1,059K Repurchase of common stock$5,870K Dividends paid$858K Deferred revenue-$534K Operating leaseliabilities-$294K Accrued commissions-$268K Other accruedexpenses-$263K Net income (loss)-$154K Other currentliabilities-$119K Amounts held in ewallets-$80K Other assets$58K Other current assets$57K Net accretion ofmarketable securities-$29K